Vision, Value, Trust
GPB Capital Holdings, LLC (GPB Capital) is a New York-based private equity firm with a focus on acquiring middle-market, income-producing portfolio companies. We provide our portfolio company operators with the strategic planning, managerial insight, and capital needed to enable strong businesses to achieve a new level of growth and profitability.
GPB Capital’s access to proprietary deal flow and long-standing personal relationships with business owners can be combined to create distinctive transactions. GPB Capital aims to develop investor friendly structures that allow our clients to own businesses which generate steady cash flows and who we believe will shape the future of their dynamic industries, with an emphasis on:
- Automotive Retail
- Managed IT Services
- Life Sciences
The franchised auto dealer industry is the largest retail business in the U.S. according to the National Automobile Dealers Association and historically has performed well in both challenging and favorable economic environments2. Industry analysts predict the future growth outlook remains strong and dealership profitability is expected to remain attractive in future years2. GPB Capital’s acquisition strategy is to focus on geographically diverse dealership assets located in attractive growth markets that are backed by stable manufacturers with a demonstrated commitment to their U.S. automotive presence.
The industrialization of technology over the last decade has changed the way businesses evaluate and consume IT. Companies now view technology as an operating cost rather than a capital investment. Companies are under pressure to manage IT infrastructure and yet for small companies, hiring full time employees and building an IT department is prohibitively expensive. These trends have fueled explosive growth in the managed IT services space. GPB intends to target IT Services companies in strategic U.S. markets who provide affordable solutions to the complex technology problems of businesses.
The life sciences sector is in a state of dynamic change. Increasingly frequent research breakthroughs, adoption of new technologies and the ongoing operational overhaul in the medical industry value chain has sped the rate of sector innovation, driven greater efficiencies and delivered opportunities for growth and investment return. GPB Capital targets revenue-stage companies in underserved, niche areas, including approved drugs, orphan drug opportunities, generic drugs, devices, diagnostics, and tools. Acquisitions are expected to be public companies, or companies that intend to go public within 12 months.
GPB Capital Holdings, LLC is a New York-based private equity firm which emerged from the public accounting firm Gentile, Pismeny & Brengel LLP (GP&B). The principals of GPB Capital bring over twenty years of private equity experience and are focused on developing institutional quality, income generating investment solutions for investors. Most importantly, the team’s competitive advantage stems from a creative approach to deal structuring combined with significant access to proprietary deal flow with a focus in Automotive Retail, Managed IT Services and Life Sciences.
Founder & Chief Executive Officer
Mr. Gentile is jointly responsible for the management of GPB Capital, including the formulation of strategy, oversight of investment policy and leadership of the Investment Committee. Prior to founding GPB Capital, Mr. Gentile spent 25 years at the Corporate Advisory and Accounting practice of GP&B in New York. During his tenure there, he developed and maintained executive level relationships with many of the firm’s 3,000+ entrepreneurial, corporate executive and high-net-worth clients.
During his career at GP&B, Mr. Gentile provided financial and strategic advisory to various companies with a combined enterprise value over $1 billion in the private and public markets.
Mr. Gentile is acting Chairman and serves on the Board of Directors of AlphaServe Technologies, Qello Holdings, LLC and QT Ultrasound, LLC.
Brian Marshall, CPA
Chief Operating Officer
Mr. Marshall oversees GPB Capital’s operations, including deal flow, the due diligence process, acquisitions, and after-care of investments. He is also responsible for GPB Capital’s Quality Control division, ensuring investments are meeting their goals.
Prior to joining GPB Capital, Mr. Marshall spent 16 years in management and accounting positions for companies ranging from an international not-for-profit to a small family business and boutique public accounting firms. Mr. Marshall brings a proven track record of statistical analysis and management techniques to the Firm.
He has extensive experience with audits in a variety of industries, including defined benefit pension plans with assets up to $800 million. Mr. Marshall uses his unique blend of education in accounting, and his experience as a business owner and manager to develop and implement GPB Capital’s due diligence and asset management process.
Chief Financial Officer
Mr. Frangioni is responsible for overseeing all accounting, finance, and fundraising at GPB Capital. Mr. Frangioni brings over 10 years of work experience in private equity and alternative investments.
Prior to joining GPB Capital, Mr. Frangioni was Vice President of Investment Funds at Gemini Real Estate Advisors, where he assisted in the launch of two private equity funds and oversaw six funds with marked value at over $250 million. Previously he served as Fund Controller at Marathon Asset Management, Monday Properties and Tishman Speyer.
GPB Automotive Retail
Mr. Dibré is responsible for implementing GPB Capital’s Automotive Retail strategy, which includes sourcing, structuring, closing and monitoring potential acquisitions and divestitures. He works in conjunction with Jeffery Lash, also a Co-Director of GPB Automotive Retail, to increase sales, service, and finance income while also improving operational efficiencies to increase profitability at the Firm’s dealerships. Mr. Dibré brings over 20 years of automotive retail expertise with a focus on sales, financing, and dealership turnaround.
Prior to joining GPB Capital, Mr. Dibré was the owner of multiple auto dealer franchises in New York, New Jersey, Virginia and California. The total sales at his dealerships exceeded $800 million annually in 2013, and his stores consistently rank among the top dealerships in the nation in both number of units sold and customer satisfaction.
Co-Director GPB Automotive Retail
Mr. Lash is responsible for formulating GPB Capital’s Automotive Retail strategy, which includes developing the Firm’s investment strategy, risk management framework and portfolio strategy. He brings to GPB Capital more than 23 years of automotive retail expertise with a focus on operations and underperforming dealership turnaround. At GPB Capital, Mr. Lash oversees the various operating partners to enhance operational efficiencies at the dealership level while enhancing its senior leadership team.
Prior to joining GPB Capital, Mr. Lash’s accomplishments included running a portfolio of dealerships, restructuring large Automotive Retail portfolios and working as a consultant for a software company whose product focused on improving operations and providing strategic planning steps crucial to an automotive dealership.
Scott Naugle, CPA
Chief Financial Officer
Mr. Naugle is responsible for overseeing GPB Capital’s automotive dealership investments including financial reporting, risk management, procurement, acquisition due diligence, internal audit, and profit optimization. With more than 20 years of accounting and corporate finance experience, Mr. Naugle is a results-oriented leader with experience in the retail, distribution, financial services, and leasing industries.
Prior to joining GPB Capital, he served as Director of Corporate Finance and Accounting at DCH Automotive Group where he successfully led the due diligence team in the acquisition of two large dealerships with revenues exceeding $200 million annually. Previously he served as Financial Officer and Treasurer at Holman Automotive Group, Inc. and was a Senior Auditor at Deloitte & Touche.
Managed IT Services
Mr. Frost is responsible for formulating GPB Capital’s Managed IT Services strategy, and sourcing, structuring, closing and monitoring potential acquisitions and divestitures. With more than 20 years of leadership experience, Mr. Frost brings a proven ability to commercialize technology and drive revenue. With a hands-on approach, he has successfully raised capital while directing, articulating, advancing, and evaluating overall strategic and tactical planning for his organizations.
Prior to joining GPB Capital, Mr. Frost served as Senior Director, Retail & Commercial Systems, for Siemens Industry, where he developed the strategy and built the nationwide U.S. team responsible for
revenue from small commercial buildings for the $1.2 Billion Siemens U.S. Sector of Building Technologies.
Previously, Mr. Frost served as President of SureGrid, where he helped architect and implement a plan that resulted in 100% annual growth in core business with over $3 million in first year revenues. Site Control & SureGrid was later acquired by Siemens.
Additional career highlights include, CEO and President of ClearCube Technology and Founder and President of TechWorks (acquired by MELCO Japan). Mr. Frost was named a High Technology Entrepreneur of the Year by Ernst & Young for his role with TechWorks.
Mr. Myrianthopoulos is responsible for formulating GPB Capital’s Life Sciences strategy, and sourcing, structuring, closing and monitoring potential acquisitions and divestitures. Bringing more than 18 years of experience, he is known for his strength in identifying, financing, developing, managing and publicly exiting emerging biotechnology investments. Mr. Myrianthopoulos is a Managing Director of the Life Sciences Investment Banking practice at Aegis Capital Corp.
Prior to joining Aegis, Mr. Myrianthopoulos served as CFO and Board Member of Soligenix, Inc., a clinical stage biopharmaceutical company, where he led seventeen financings totaling over $150 million in proceeds, four company Acquisitions and thirteen licensing deals. Previously, he was co-founder, Board Director, CFO, COO, and VP of Finance of Discovery Laboratories, Inc., where he led Discovery’s reverse merger with Ansan Pharmaceuticals to go public in addition to managing its merger with Acute Therapeutics.